Ayushman Bharat Yojana Unlocks Vast Opportunities in Healthcare and Pharma Sector: Deputy Chief Minister Shri Shukla

Deputy Chief Minister Rajendra Shukla said that the health sector is a key priority for Prime Minister Narendra Modi. He stated that the government’s primary goal is to ensure easy access to education and healthcare services for every individual, especially those at the grassroots level. Investment opportunities in Madhya Pradesh are expanding rapidly, supported by infrastructure development and investor-friendly policies that encourage business growth.He highlighted that the Ayushman Bharat Yojana has created vast opportunities in the healthcare and pharmaceutical sectors, with significant potential for private sector involvement. Currently, there is no shortage of demand for healthcare services in India and Madhya Pradesh. The state is developing common facility centers and has dry ports, making it well-positioned for logistics and supply chain operations.He said that Chief Minister Dr. Mohan Yadav will engage in one-on-one discussions on special proposals to introduce necessary public-interest provisions that benefit all stakeholders. Inviting investors to explore opportunities in the health and medical sector, he addressed the Health Care, Pharmaceuticals, and Medical Devices session, encouraging investments in these critical areas. 

Government’s Vision and Policies Foster Industrial Growth: Minister of State Shri Patel

Minister of State for Public Health and Medical Education Shri Narendra Shivaji Patel said that the government’s intentions and policies are conducive to industrial development. An unprecedented industrial environment has been created in Madhya Pradesh under the leadership of Prime Minister Shri Narendra Modi, which is attracting investors.

Madhya Pradesh Emerging as a Prime Destination for the Pharma Sector with Strong Policies, Infrastructure, and Strategic Location: Secretary Shri Agarwal

Union Secretary for Pharmaceuticals, Shri Amit Agarwal said that Madhya Pradesh is emerging as an ideal destination for the pharmaceutical sector due to its ease of doing business policies, logistics hub, and strategic central location. The sector is receiving a further boost through the Ujjain Medical Device Park, which is expected to drive investment and production. He highlighted that India is a global leader in drug manufacturing, with exports valued at $50 billion, accounting for 20% of the total global generic drug market. India exports medicines to 190 countries, adhering to stringent quality standards. The medical device sector, currently valued at $15.35 billion, is witnessing significant growth, with advanced medical devices such as linacs, cobalt units, MRI machines, CT scans, valves, occluders, and implants being produced at competitive prices. India exports medical devices worth $4 billion to 173 countries.Additionally, under medical tourism; 2.3 million medical visas have been issued in the last five years. The life sciences start-up ecosystem is expanding rapidly, with 98 approved biosimilar drugs and over 4 lakh trained professionals specializing in AI-related healthcare solutions.

Principal Secretary for Public Health and Medical Education, Shri Sandeep Yadav said that Madhya Pradesh offers a large consumer market, central location, land pool, surplus power, and essential infrastructure. The state ranks at the top in ease of doing business, enabling industries to commence operations within 30 to 45 days. He further noted that Madhya Pradesh is rapidly developing as a key logistics hub, with an extensive network of industrial corridors, airports, financial incentives, strong law enforcement, and a skilled workforce. The state is making significant progress in the pharmaceuticals and medical devices sector, with over 300 pharma and API companies and more than 50 medical device firms operating. The Medical Device Park in Ujjain is set to enhance the production of health equipment. To further strengthen healthcare infrastructure, private sector participation is being encouraged for the establishment of 12 new medical colleges, community health centers, and diagnostic services through the Public-Private Partnership (PPP) model.

Madhya Pradesh a suitable place for investment

Experts from the health, pharmaceuticals, and medical devices sector described Madhya Pradesh as a suitable destination for investment. Shri Rahul Awasthi, Global Head of Operations and Senior Vice President, Sun Pharmaceutical Industries Limited, stated that the healthcare industry in the state has a strong network and a well-developed ecosystem. Shri Rajiv Chhibber, Vice President – External Affairs, Sahajanand Medical Technologies Limited, highlighted that the easy availability of raw materials is boosting industrial growth. Shri Gaurav Agarwal, Managing Director, Involution Health Care Private Limited, and Shri Akshat Chaudhary, CEO, Renee Life Science Private Limited, emphasized that Madhya Pradesh has a vast talent pool, fulfilling the workforce needs of the pharma and health sectors. They noted that investments have been flowing into this sector for the past 15 years, positioning Madhya Pradesh as a key hub for API production.

Shri Biwash Chakraborty, Head – Regulatory, Quality, and Government Affairs, BioMerieux India Private Limited, and Shri Achintya Das, Head – AI and Data, Syngene, also praised the state’s industrial policies. Shri Ajit Kumar Jain, Managing Director and CFO of IPCA Laboratories, announced an investment of Rs 250 crore in a biosimilar plant. He acknowledged the supportive role of the drug control, energy, and other departments in strengthening industries within the state.

Senior interventional cardiologist of Apollo Hospital, Prof. Dr. Vivek Gupta, shared insights on the quality of healthcare services and the scope for investment. The session was conducted by Shri S.S. Sundaram. A special film showcasing investment opportunities and policy support in the pharmaceutical sector of Madhya Pradesh was also screened on this occasion.